| Dr Daniel Lee Dragomire, MD | |
|
318 Waterman Ave, East Providence, RI 02914-3525 | |
| (401) 438-5950 | |
| (401) 435-6700 |
| Full Name | Dr Daniel Lee Dragomire |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 27 Years |
| Location | 318 Waterman Ave, East Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134192206 | NPI | - | NPPES |
| 10334 | Other | RI | RI BLUE CROSS |
| 1134192206 | Other | TUFTS | |
| 050352774 | Other | RI | UNITEDHEALTH |
| 4155 | Other | RI | NEIGHBORHOOD OF RI |
| J40750 | Other | MA | BLUE CROSS MA |
| 0613770 | Other | CIGNA | |
| 110075536A | Medicaid | MA | |
| 407358 | Other | RI | RI BLUE CHIP |
| 00000038908 | Other | BOSTON MEDICAL | |
| 1405317 | Other | AETNA | |
| 73058525 | Medicaid | RI | |
| AA67162 | Other | MA | HARVARD PILGRIM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | MD10334 (Rhode Island) | Primary |
| 207RN0300X | Internal Medicine - Nephrology | 229167 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dialysis Center Of West Warwick | Warwick, RI | Dialysis facility |
| Dialysis Center Of Johnston | Johnston, RI | Dialysis facility |
| Dialysis Center Of Providence | Providence, RI | Dialysis facility |
| Dialysis Center Of East Providence | East providence, RI | Dialysis facility |
| Rhode Island Hospital | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Kent County Memorial Hospital | Warwick, RI | Hospital |
| Newport Hospital | Newport, RI | Hospital |
| Our Lady Of Fatima Hospital | North providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Inc | 8426061185 | 9 |
| Nephrology Associates Inc | 8426061185 | 9 |
News Archive
As we get older, the trillions of cells in our body do too. And like us, they become less resilient and able to weather the stress of everyday life. Our skin especially tells the tale of what's happening throughout our bodies.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial with aldoxorubicin for the treatment of unresectable glioblastoma multiforme (GBM), a deadly form of brain cancer.
Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest.
"In recent years, Kyrgyzstan has benefited from a significant increase in international funding to improve health care," but, "[d]espite this influx of international funding, many people in Kyrgyzstan are unable to get the lifesaving medicines that they need," Madina Tokombaeva, director of the Harm Reduction Network (HRN) in Kyrgyzstan, and Maryam Beishenova, program coordinator at HRN, write in this Open Society Foundations blog post.
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.
› Verified 7 days ago
| Entity Name | The Providence Community Health Centers Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053313593 PECOS PAC ID: 9335050962 Enrollment ID: O20040608000007 |
News Archive
As we get older, the trillions of cells in our body do too. And like us, they become less resilient and able to weather the stress of everyday life. Our skin especially tells the tale of what's happening throughout our bodies.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial with aldoxorubicin for the treatment of unresectable glioblastoma multiforme (GBM), a deadly form of brain cancer.
Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest.
"In recent years, Kyrgyzstan has benefited from a significant increase in international funding to improve health care," but, "[d]espite this influx of international funding, many people in Kyrgyzstan are unable to get the lifesaving medicines that they need," Madina Tokombaeva, director of the Harm Reduction Network (HRN) in Kyrgyzstan, and Maryam Beishenova, program coordinator at HRN, write in this Open Society Foundations blog post.
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.
› Verified 7 days ago
| Entity Name | Nephrology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366426801 PECOS PAC ID: 8426061185 Enrollment ID: O20060724000322 |
News Archive
As we get older, the trillions of cells in our body do too. And like us, they become less resilient and able to weather the stress of everyday life. Our skin especially tells the tale of what's happening throughout our bodies.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial with aldoxorubicin for the treatment of unresectable glioblastoma multiforme (GBM), a deadly form of brain cancer.
Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest.
"In recent years, Kyrgyzstan has benefited from a significant increase in international funding to improve health care," but, "[d]espite this influx of international funding, many people in Kyrgyzstan are unable to get the lifesaving medicines that they need," Madina Tokombaeva, director of the Harm Reduction Network (HRN) in Kyrgyzstan, and Maryam Beishenova, program coordinator at HRN, write in this Open Society Foundations blog post.
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Lee Dragomire, MD 81 Rumstick Rd, Barrington, RI 02806-4821 Ph: (401) 245-4205 | Dr Daniel Lee Dragomire, MD 318 Waterman Ave, East Providence, RI 02914-3525 Ph: (401) 438-5950 |
News Archive
As we get older, the trillions of cells in our body do too. And like us, they become less resilient and able to weather the stress of everyday life. Our skin especially tells the tale of what's happening throughout our bodies.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial with aldoxorubicin for the treatment of unresectable glioblastoma multiforme (GBM), a deadly form of brain cancer.
Investigators from the Centers for Disease Control and Prevention (CDC) have determined that the majority of primary care providers continue to recommend annual cervical cancer screening, and less than 15% would extend the screening interval when using the Papanicolaou test and human papillomavirus (HPV) test together, as some guidelines suggest.
"In recent years, Kyrgyzstan has benefited from a significant increase in international funding to improve health care," but, "[d]espite this influx of international funding, many people in Kyrgyzstan are unable to get the lifesaving medicines that they need," Madina Tokombaeva, director of the Harm Reduction Network (HRN) in Kyrgyzstan, and Maryam Beishenova, program coordinator at HRN, write in this Open Society Foundations blog post.
Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.
› Verified 7 days ago
Matthew J Franco, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave, Suite 401, East Providence, RI 02914 Phone: 800-508-4908 Fax: 401-228-6236 | |
Mr. Michael F Gilson, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave, 2nd Floor, East Providence, RI 02914 Phone: 401-606-1004 Fax: 401-606-1153 | |
Dr. Christopher Song, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave, East Providence, RI 02914 Phone: 401-606-1004 Fax: 401-606-1153 | |
Dr. Ricardo Rafael Correa Marquez, M.D Nephrology Medicare: Medicare Enrolled Practice Location: 900 Warren Avenue, Suite 300, East Providence, RI 02914 Phone: 786-246-5719 | |
May Min, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 950 Warren Ave Ste 301, East Providence, RI 02914 Phone: 401-606-4260 | |
Prerna Ganjoo, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 318 Waterman Ave, East Providence, RI 02914 Phone: 401-438-5950 Fax: 401-435-6700 | |
Mordecai Jeremiah Stolk, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 318 Waterman Ave, East Providence, RI 02914 Phone: 401-438-5950 Fax: 401-435-6700 |